SGLT Inhibitor Intermediate Crystallization for Impurity Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for synthesizing diphenylmethane derivatives for SGLT inhibitors face challenges in controlling related substances during the reaction process, leading to increased purification costs and reduced yield due to the need for multiple purification steps and the difficulty in handling related substances in a continuous process.

Innovation Solution

A novel intermediate and method are developed to purify related substances in situ, allowing for a single purification step and improved control of substance quality, using a six-step process that includes crystallization to remove most related substances, thereby simplifying the synthesis and enhancing yield.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Device complexity

If a four-step continuous process is used to synthesize diphenylmethane derivative, then the synthesis pathway is simplified, but the related substances cannot be removed and quality control becomes difficult

Engineering Contradiction:
Improvesynthesis pathway complexityVSAvoidrelated substances quality control
Core Design Contradiction:
Device complexityVSManufacturing precision

Solution Approach 1:

The continuous four-step process is segmented into discrete steps with intermediate purification points. The synthesis is divided into modules where related substances can be removed at strategic intermediate stages, allowing quality control without requiring a completely different synthesis architecture.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Purification actions are performed preliminarily at intermediate stages rather than only at the final stage. By removing related substances at c5 and other intermediate points, the burden of final purification is reduced and quality is controlled step-by-step throughout the synthesis process.

Inventive Principle:
Principle #10Preliminary action

2Device complexity

If purification is performed only at the final stage c7, then the process is simpler, but multiple purification steps are required to meet quality standards, increasing cost and reducing yield

Engineering Contradiction:
Improvepurification process complexityVSAvoidproduction yield
Core Design Contradiction:
Device complexityVSProductivity

Solution Approach 1:

Purification is performed preliminarily at intermediate stages (c5, c7, and other strategic points) rather than consolidating all purification at the final stage. This preliminary action removes related substances when they are easier to separate, reducing the burden on final purification and improving overall yield.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The presence of related substances that would normally require extensive final purification is converted into an opportunity for staged removal. By performing purification at intermediate stages, the related substances are removed when their separation is most efficient, turning a potential burden into a benefit for overall process efficiency.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

3Ease of manufacture

If intermediate c5 is stored in crude state, then storage is simpler, but chemical stability degrades and continuous synthesis becomes burdensome

Engineering Contradiction:
Improveintermediate storage simplicityVSAvoidchemical stability of intermediate
Core Design Contradiction:
Ease of manufactureVSStability of the object's composition

Solution Approach 1:

The intermediate c5 is purified preliminarily at the c5 stage rather than being stored in crude form. This preliminary purification removes impurities that would cause degradation, allowing the intermediate to be stored stably or used immediately in the next synthesis step without compromising chemical stability.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method achieves high-quality synthesis of the diphenylmethane derivative with reduced purification steps, minimizing related substances in the final product and maximizing production yield.

Implementation Method 1

crystallization to remove most related substances

Methodology Applied
Scientific EffectCrystallization: Crystallisation

Data Source

PatentUS20260085065A1Crystalline form of SGLT inhibitor
Publication Date: 2026.03.26 DAEWOONG PHARM CO LTD
  • US20260085065A1 patent drawing
  • US20260085065A1 patent drawing
  • US20260085065A1 patent drawing

AI summary

An intermediate useful for the synthesis of an SGLT inhibitor and a method for preparing an SGLT inhibitor are provided. By employing an intermediate having Chemical Formula 5, the difficulty of purification with existing processes can be solved, the quality requirements for related substances can be achieved with only one purification step, and the quality control problem in each step can be solved by performing several steps in situ. A method for synthesizing a compound of Chemical Formula 1 by using a compound of Chemical Formula 5 enables purification in an earlier step, thereby solving the problems of existing synthesis processes, in which the quality requirements for related substances were difficult to control step-by-step due to a continuous process, thereby minimizing the amount of related substances in the final product. In addition, the yield of a diphenylmethane derivative according to Chemical Formula 1 is increased.